GAMBRO LUNDIA AB

GAMBRO LUNDIA AB has been granted 338 US utility patents between 2015 and 2025, placing GAMBRO LUNDIA AB at rank #1,252 across all assignees tracked by PlainPatent. This portfolio spans 65 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.7 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, GAMBRO LUNDIA AB is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 63.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 189 grants, compared with 149 in the 2015–2019 window — a +27% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. GAMBRO LUNDIA AB's 20.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 65 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark GAMBRO LUNDIA AB against peers pursuing similar technology classes.